Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular oxygen and the reducing agent NADPH (nicotinamide adenine dinucleotide phosphate hydrogen) to trigger substrate oxidation.

Oxidative reactions can occur at different carbon points in the drug molecule, culminating in the introduction of hydroxyl, carbonyl, or other polar functional groups. For instance, aromatic carbon atom oxidation can transform phenytoin into p-hydroxy phenytoin. Oxidation of aliphatic carbon atoms, as seen in ethanol metabolism, results in alcohols or carboxylic acids. Nitrogen-containing compounds like codeine can undergo various transformations, including N-demethylation, leading to morphine. Sulfur-containing compounds, such as omeprazole, can be converted to sulfoxides or sulfones. Lastly, oxidation of alcohol, carbonyl, and acid functions can lead to aldehydes, ketones, or carboxylic acids.

These reactions are pivotal for drug metabolism, enhancing hydrophilicity and promoting easier elimination. They also facilitate the formation of active metabolites or detoxify harmful compounds. In summary, phase I oxidative biotransformation reactions are indispensable in ensuring the safe and effective use of drugs in the body.

장에서 5:

article

Now Playing

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

148 Views

article

5.1 : Drug Biotransformation: 개요

Pharmacokinetics: Drug Biotransformation

33 Views

article

5.3 : I단계 반응: 지방족 및 방향족 탄소 함유 시스템의 산화

Pharmacokinetics: Drug Biotransformation

51 Views

article

5.4 : I상 반응: 탄소-헤테로원자 및 기타 시스템의 산화

Pharmacokinetics: Drug Biotransformation

14 Views

article

5.5 : I단계 반응: 환원적 반응

Pharmacokinetics: Drug Biotransformation

114 Views

article

5.6 : I상 반응: 가수분해 반응

Pharmacokinetics: Drug Biotransformation

8 Views

article

5.7 : Phase II Conjugation Reactions: 개요

Pharmacokinetics: Drug Biotransformation

18 Views

article

5.8 : 2상 반응: 글루쿠로니드화

Pharmacokinetics: Drug Biotransformation

22 Views

article

5.9 : 2상 반응: α-아미노산을 사용한 황화 및 접합

Pharmacokinetics: Drug Biotransformation

30 Views

article

5.10 : 2상 반응: 글루타티온 접합 및 머캅튀르산 형성

Pharmacokinetics: Drug Biotransformation

25 Views

article

5.11 : 2상 반응: 아세틸화 반응

Pharmacokinetics: Drug Biotransformation

45 Views

article

5.12 : 2상 반응: 메틸화 반응

Pharmacokinetics: Drug Biotransformation

27 Views

article

5.13 : 2상 반응: 기타 접합 반응

Pharmacokinetics: Drug Biotransformation

7 Views

article

5.14 : 약물 생체 내 변형에 영향을 미치는 요인 : 약물의 물리 화학적 및 화학적 특성

Pharmacokinetics: Drug Biotransformation

14 Views

article

5.15 : 약물 생체 내 변환에 영향을 미치는 요인 : 생물학적

Pharmacokinetics: Drug Biotransformation

19 Views

JoVE Logo

개인 정보 보호

이용 약관

정책

연구

교육

JoVE 소개

Copyright © 2025 MyJoVE Corporation. 판권 소유